Skip to content
10-Q

Quarterly Report

BioDelivery Sciences International, Inc.

0001103021-21-000042

← back to feed
Filed
May 6, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 4, 2021 98.55M sh
Shares Diluted Q1 2021 · Mar 31, 2021 105.4M sh
Shares Diluted Q1 2021 · Mar 31, 2020 106.97M sh
Stock Repurchased Q1 2021 · Mar 31, 2021 $6.15M
Stock Repurchased Q1 2021 · Mar 31, 2020 $0
Capex Q1 2021 · Mar 31, 2021 $296K
Capex Q1 2021 · Mar 31, 2020 $0
Operating Cash Flow Q1 2021 · Mar 31, 2021 $11.1M
Operating Cash Flow Q1 2021 · Mar 31, 2020 $6.39M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $116.44M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $111.58M
Stockholders Equity Q1 2021 · Mar 31, 2021 $108.85M
Stockholders Equity Q1 2021 · Dec 31, 2020 $108.23M
Stockholders Equity Q1 2021 · Mar 31, 2020 $76.59M
Stockholders Equity Q1 2021 · Dec 31, 2019 $69.76M
Current Liabilities Q1 2021 · Mar 31, 2021 $54.58M
Current Liabilities Q1 2021 · Dec 31, 2020 $53M
Total Liabilities Q1 2021 · Mar 31, 2021 $133.28M
Total Liabilities Q1 2021 · Dec 31, 2020 $131.66M
Current Assets Q1 2021 · Mar 31, 2021 $186.15M
Current Assets Q1 2021 · Dec 31, 2020 $182.39M
Total Assets Q1 2021 · Mar 31, 2021 $242.13M
Total Assets Q1 2021 · Dec 31, 2020 $239.89M
Eps Diluted Q1 2021 · Mar 31, 2021 $0.05
Eps Diluted Q1 2021 · Mar 31, 2020 $0.05
Eps Basic Q1 2021 · Mar 31, 2021 $0.05
Eps Basic Q1 2021 · Mar 31, 2020 $0.05
Net Income Q1 2021 · Mar 31, 2021 $5.24M
Net Income Q1 2021 · Mar 31, 2020 $4.97M
Operating Income Q1 2021 · Mar 31, 2021 $7.44M
Operating Income Q1 2021 · Mar 31, 2020 $5.98M
Revenue Q1 2021 · Mar 31, 2021 $41.02M
Revenue Q1 2021 · Mar 31, 2020 $38.28M